Lv2
160 积分 2021-03-03 加入
2021 ESC/EACTS Guidelines for the management of valvular heart disease
11小时前
待确认
Correction to: 2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)
12小时前
已完结
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes
2天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
2天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2天前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
4天前
已完结
Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial
5天前
已完结
Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLD
5天前
已完结
皖公网安备34019202002308
